查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1586417

類器官和球體市場、佔有率、規模、趨勢、行業分析報告：按類型、按應用、按最終用途、按地區、按細分市場、預測，2024-2032 年

Organoids and Spheroids Market Share, Size, Trends, Industry Analysis Report - By Type (Organoids and Spheroids), Application, End Use, and Region; Segment Forecasts, 2024-2032
出版日期: | 出版商: Polaris Market Research | 英文 116 Pages | 商品交期: 最快1-2個工作天內

價格

根據 Polaris Market Research 的一項新研究，到 2032 年，全球類器官和球體市場規模預計將達到 51.1759 億美元。該研究報告提供了對當前市場動態的詳細洞察，並對未來市場成長進行了分析。

CRISPR/Cas-9等基因編輯技術的發展使研究人員能夠對幹細胞基因進行精確的改變，從而產生模仿疾病狀態的類器官和球體。這些進展為複雜的細胞狀態提供了寶貴的見解，並為研究人員提供了疾病研究和藥物測試的改進模型。幹細胞技術和 3D 培養方法的進步相結合，在類器官和球體市場的穩定成長中發揮關鍵作用。2024 年 1 月，南加州大學USC研究人員開發了一種新的人類大腦類器官模型，用於研究小腦發育和神經系統疾病中小腦病理的出現。

患者特異性類器官代表了推進個人化醫療的強大平台，並透過對從患者身上採集的組織進行潛在藥物測試，正在推動類器官和球體市場的成長。類器官和球體在研究和臨床環境中的臨床重要性對於開發個人化類器官模型和促進 P4 醫學的進步至關重要。

3D生物列印技術和器官晶片平台的發展將大大推進類器官和球體的研究。3D 生物列印能夠創建高精度的複雜、客製化的組織模型，從而增強藥物測試和個人化醫療。器官晶片平台以微型方式重建器官功能，從而實現動態建模、高通量篩選和個人化治療策略。這些創新提高了生物醫學研究的準確性和相關性，促進更有效的藥物開發和疾病理解。

類器官和球體市場報告亮點

按類型劃分，球體部分由於其在藥物發現和疾病建模中的重要應用，將在 2023 年佔據主要佔有率。

由於癌症、神經退化性疾病和傳染病等疾病的發生率不斷增加以及對先進研究模型的需求不斷增長，預計類器官領域將在預測期內快速增長。

從應用來看，發育生物學領域因其在器官形成機制的應用而在 2023 年佔據市場主導地位。

由於類器官和球體越來越多地用於個人化醫療，北美將在 2023 年佔據最大佔有率。

主要公司包括 3D Biomatrix、3D Biotek、AMS Biotechnology、Cellsce、Greiner Bio-One 和 Thermo Fisher Scientific。

目錄

第1章簡介

第2章 執行摘要

第3章 研究方法

第4章全球類器官與球體市場洞察

  • 市場快照
  • 類器官和球體市場動態
    • 驅動因素和機遇
      • 幹細胞研究進展
      • 擴大藥物發現和個人化醫療的應用
    • 限制因素和課題
      • 開發和生產成本高
  • PESTEL 分析
  • 類器官和球體市場應用趨勢
  • 價值鏈分析
  • COVID-19 影響分析

第5章全球類器官和球體市場：按類型

  • 主要發現
  • 介紹
  • 類器官
  • 球體

第6章全球類器官與球體市場：依應用分類

  • 主要發現
  • 介紹
  • 發育生物學
  • 個人化醫療
  • 再生醫學
  • 疾病病理學研究
  • 藥物毒性及藥效測試

第7章全球類器官和球體市場：依最終用途分類

  • 主要發現
  • 介紹
  • 生物技術和製藥業
  • 學術研究機構
  • 醫院和診斷中心

第8章全球類器官和球體市場：按地區

  • 主要發現
  • 介紹
    • 類器官和球體市場評估：地區，2019-2032
  • 北美
    • 北美：按類型劃分，2019-2032
    • 北美：依申請劃分，2019-2032
    • 北美：依最終用途分類，2019-2032
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲：依類型劃分，2019-2032
    • 歐洲：依申請劃分，2019-2032
    • 歐洲：依最終用途分類，2019-2032
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
    • 歐洲其他地區
  • 亞太地區
    • 亞太地區：依類型劃分，2019-2032
    • 亞太地區：依應用劃分，2019-2032
    • 亞太地區：依最終用途分類，2019-2032
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
    • 澳洲
    • 亞太其他地區
  • 中東/非洲
    • 中東和非洲：按類型劃分，2019-2032
    • 中東和非洲：依申請劃分，2019-2032
    • 中東和非洲：依最終用途分類，2019-2032
    • 沙烏地阿拉伯
    • 阿拉伯聯合酋長國
    • 以色列
    • 南非
    • 其他中東/非洲
  • 拉丁美洲
    • 拉丁美洲：按類型劃分，2019-2032
    • 拉丁美洲：按應用劃分，2019-2032
    • 拉丁美洲：依最終用途分類，2019-2032
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他拉丁美洲

第9章競爭格局

  • 擴張和收購分析
    • 擴張
    • 收購
  • 夥伴關係/協作/協議/揭露

第10章 公司簡介

  • 3D Biomatrix
  • 3D Biotek LLC
  • AMS Biotechnology Limited
  • Cellesce Ltd.
  • TheWell Bioscience
  • Greiner Bio-One
  • Hubrecht Organoid Technology（HUB）
  • InSphero
  • Lonza
  • Merck KGaA
  • Prellis Biologics
  • STEMCELL Technologies Inc.
  • Thermo Fisher Scientific, Inc.
Product Code: PM1782

The global organoids and spheroids market size is expected to reach USD 5,117.59 million by 2032, according to a new study by Polaris Market Research. The report "Organoids and Spheroids Market Share, Size, Trends, Industry Analysis Report - By Type, Application, End Use, and Region; Segment Forecasts, 2024-2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The development of genetic editing techniques such as CRISPR/Cas-9 has enabled researchers to make precise changes to genes in stem cells, leading to the creation of organoids and spheroids that replicate disease conditions. These advancements have provided researchers with improved models for studying diseases and testing drugs, yielding valuable insights into complex cellular conditions. The combination of progress in stem cell technology and 3D culture methods has played a crucial role in the steady growth of the organoids and spheroids market. In January 2024, USC researchers developed a new human brain organoid model to study cerebellum development and the emergence of cerebellar pathology in neurological disease.

Patient-specific organoids represent a robust platform for advancing personalized medicine and driving the growth of the organoids and spheroids market by enabling the testing of potential drugs on tissues sourced from patients, which provides valuable insights into individual therapy responses. The clinical importance of organoids and spheroids in both research and clinical practice is crucial for developing personalized organoid models and furthering the progress of P4 medicine.

The development of 3D bioprinting technologies and organ-on-a-chip platforms significantly advances organoid and spheroid research. 3D bioprinting enables the creation of complex, customized tissue models with high precision, enhancing drug testing and personalized medicine. Organ-on-a-chip platforms replicate organ functions in miniature, allowing for dynamic modeling, high-throughput screening, and personalized treatment strategies. Together, these innovations improve the accuracy and relevance of biomedical research, facilitating more effective drug development and disease understanding.

Organoids and Spheroids Market Report Highlights

Based on type, the spheroids segment held a larger share in 2023, owing to their significant use in drug discovery and disease modeling.

The organoids segment is projected to grow rapidly during the forecast period, fueled by rising occurrences of diseases such as cancer, neurodegenerative disorders, and infectious diseases, driving demand for advanced research models.

By application, the developmental biology segment dominated the market in 2023, owing to its application in the mechanism of organogenesis.

North America holds the largest share in 2023, owing to the rising use of organoids and spheroids for personalized medicine.

A few key players are 3D Biomatrix, 3D Biotek, AMS Biotechnology, Cellesce, Greiner Bio-One, and Thermo Fisher Scientific.

Polaris Market Research has segmented the organoids and spheroids market report on the basis of type, application, end use, and region:

By Type Outlook (Revenue - USD million, 2019-2032)

  • Organoids
  • By Type
  • Neural Organoids
  • Hepatic Organoids
  • Intestinal Organoids
  • Other Organoids
  • By Method
  • General Submerged Method for Organoid Culture
  • Crypt Organoid Culture Techniques
  • Air Liquid Interface (ALI) Method for Organoid Culture
  • Clonal Organoids from Lgr5+ Cells
  • Brain and Retina Organoid Formation Protocol
  • Others
  • By Source
  • Primary Tissues
  • Stem Cells
  • Spheroids
  • By Type
  • Multicellular Tumor Spheroids (MCTS)
  • Neurospheres
  • Mammospheres
  • Hepatospheres
  • Embryoid Bodies
  • By Method
  • Micropatterned Plates
  • Low Cell Attachment Plates
  • Hanging Drop Method
  • Others
  • By Source
  • Cell Line
  • Primary Cell
  • iPSCs Derived Cells

By Application Outlook (Revenue - USD million, 2019-2032)

  • Developmental Biology
  • Personalized Medicine
  • Regenerative Medicine
  • Disease Pathology Studies
  • Drug Toxicity & Efficacy Testing

By End Use Outlook (Revenue - USD million, 2019-2032)

  • Biotechnology & Pharmaceutical Industries
  • Academic & Research Institutes
  • Hospitals & Diagnostic Centers

By Regional Outlook (Revenue - USD million, 2019-2032)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Rest of Asia Pacific
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Organoids and Spheroids Market Insights

  • 4.1. Organoids and Spheroids Market - Market Snapshot
  • 4.2. Organoids and Spheroids Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Advancement in stem cell research
      • 4.2.1.2. Increased application in drug discovery and personalized medicine
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High cost of development and Production
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Organoids and Spheroids Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Organoids and Spheroids Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • 5.3. Organoids
    • 5.3.1. Global Organoids and Spheroids Market, by Organoids, by Region, 2019-2032 (USD Million)
  • 5.4. Spheroids
    • 5.4.1. Global Organoids and Spheroids Market, by Spheroids, by Region, 2019-2032 (USD Million)

6. Global Organoids and Spheroids Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • 6.3. Developmental Biology
    • 6.3.1. Global Organoids and Spheroids Market, by Developmental Biology, by Region, 2019-2032 (USD Million)
  • 6.4. Personalized Medicine
    • 6.4.1. Global Organoids and Spheroids Market, by Personalized Medicine, by Region, 2019-2032 (USD Million)
  • 6.5. Regenerative Medicine
    • 6.5.1. Global Organoids and Spheroids Market, by Regenerative Medicine, by Region, 2019-2032 (USD Million)
  • 6.6. Disease Pathology Studies
    • 6.6.1. Global Organoids and Spheroids Market, by Disease Pathology Studies, by Region, 2019-2032 (USD Million)
  • 6.7. Drug Toxicity & Efficacy Testing
    • 6.7.1. Global Organoids and Spheroids Market, by Drug Toxicity & Efficacy Testing, by Region, 2019-2032 (USD Million)

7. Global Organoids and Spheroids Market, by End Use

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • 7.3. Biotechnology & Pharmaceutical Industries
    • 7.3.1. Global Organoids and Spheroids Market, by Biotechnology & Pharmaceutical Industries, by Region, 2019-2032 (USD Million)
  • 7.4. Academic & Research Institutes
    • 7.4.1. Global Organoids and Spheroids Market, by Academic & Research Institutes, by Region, 2019-2032 (USD Million)
  • 7.5. Hospitals & Diagnostic Centers
    • 7.5.1. Global Organoids and Spheroids Market, by Hospitals & Diagnostic Centers, by Region, 2019-2032 (USD Million)

8. Global Organoids and Spheroids Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Organoids and Spheroids Market Assessment, By Geography, 2019-2032 (USD Million)
  • 8.3. Organoids and Spheroids Market - North America
    • 8.3.1. North America: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
    • 8.3.2. North America: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
    • 8.3.3. North America: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.3.4. Organoids and Spheroids Market - U.S.
      • 8.3.4.1. U.S.: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.3.4.2. U.S.: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.3.4.3. U.S.: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.3.5. Organoids and Spheroids Market - Canada
      • 8.3.5.1. Canada: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.3.5.2. Canada: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.3.5.3. Canada: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • 8.4. Organoids and Spheroids Market - Europe
    • 8.4.1. Europe: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
    • 8.4.2. Europe: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
    • 8.4.3. Europe: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.4.4. Organoids and Spheroids Market - UK
      • 8.4.4.1. UK: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.4.4.2. UK: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.4.4.3. UK: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.4.5. Organoids and Spheroids Market - France
      • 8.4.5.1. France: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.4.5.2. France: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.4.5.3. France: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.4.6. Organoids and Spheroids Market - Germany
      • 8.4.6.1. Germany: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.4.6.2. Germany: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.4.6.3. Germany: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.4.7. Organoids and Spheroids Market - Italy
      • 8.4.7.1. Italy: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.4.7.2. Italy: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.4.7.3. Italy: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.4.8. Organoids and Spheroids Market - Spain
      • 8.4.8.1. Spain: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.4.8.2. Spain: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.4.8.3. Spain: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.4.9. Organoids and Spheroids Market - Netherlands
      • 8.4.9.1. Netherlands: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.4.9.2. Netherlands: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.4.9.3. Netherlands: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.4.10. Organoids and Spheroids Market - Russia
      • 8.4.10.1. Russia: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.4.10.2. Russia: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.4.10.3. Russia: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.4.11. Organoids and Spheroids Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.4.11.2. Rest of Europe: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.4.11.3. Rest of Europe: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • 8.5. Organoids and Spheroids Market - Asia Pacific
    • 8.5.1. Asia Pacific: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
    • 8.5.2. Asia Pacific: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
    • 8.5.3. Asia Pacific: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.5.4. Organoids and Spheroids Market - China
      • 8.5.4.1. China: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.5.4.2. China: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.5.4.3. China: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.5.5. Organoids and Spheroids Market - India
      • 8.5.5.1. India: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.5.5.2. India: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.5.5.3. India: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.5.6. Organoids and Spheroids Market - Malaysia
      • 8.5.6.1. Malaysia: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.5.6.2. Malaysia: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.5.6.3. Malaysia: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.5.7. Organoids and Spheroids Market - Japan
      • 8.5.7.1. Japan: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.5.7.2. Japan: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.5.7.3. Japan: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.5.8. Organoids and Spheroids Market - Indonesia
      • 8.5.8.1. Indonesia: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.5.8.2. Indonesia: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.5.8.3. Indonesia: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.5.9. Organoids and Spheroids Market - South Korea
      • 8.5.9.1. South Korea: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.5.9.2. South Korea: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.5.9.3. South Korea: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.5.10. Organoids and Spheroids Market - Australia
      • 8.5.10.1. Australia: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.5.10.2. Australia: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.5.10.3. Australia: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.5.11. Organoids and Spheroids Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.5.11.2. Rest of Asia Pacific: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.5.11.3. Rest of Asia Pacific: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • 8.6. Organoids and Spheroids Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
    • 8.6.2. Middle East & Africa: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
    • 8.6.3. Middle East & Africa: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.6.4. Organoids and Spheroids Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.6.4.2. Saudi Arabia: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.6.4.3. Saudi Arabia: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.6.5. Organoids and Spheroids Market - UAE
      • 8.6.5.1. UAE: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.6.5.2. UAE: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.6.5.3. UAE: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.6.6. Organoids and Spheroids Market - Israel
      • 8.6.6.1. Israel: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.6.6.2. Israel: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.6.6.3. Israel: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.6.7. Organoids and Spheroids Market - South Africa
      • 8.6.7.1. South Africa: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.6.7.2. South Africa: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.6.7.3. South Africa: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.6.8. Organoids and Spheroids Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.6.8.2. Rest of Middle East & Africa: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.6.8.3. Rest of Middle East & Africa: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • 8.7. Organoids and Spheroids Market - Latin America
    • 8.7.1. Latin America: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
    • 8.7.2. Latin America: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
    • 8.7.3. Latin America: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.7.4. Organoids and Spheroids Market - Mexico
      • 8.7.4.1. Mexico: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.7.4.2. Mexico: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.7.4.3. Mexico: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.7.5. Organoids and Spheroids Market - Brazil
      • 8.7.5.1. Brazil: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.7.5.2. Brazil: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.7.5.3. Brazil: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.7.6. Organoids and Spheroids Market - Argentina
      • 8.7.6.1. Argentina: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.7.6.2. Argentina: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.7.6.3. Argentina: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.7.7. Organoids and Spheroids Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.7.7.2. Rest of Latin America: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.7.7.3. Rest of Latin America: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. 3D Biomatrix
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Type Benchmarking
    • 10.1.4. Recent Development
  • 10.2. 3D Biotek LLC
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Type Benchmarking
    • 10.2.4. Recent Development
  • 10.3. AMS Biotechnology Limited
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Type Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Cellesce Ltd.
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Type Benchmarking
    • 10.4.4. Recent Development
  • 10.5. TheWell Bioscience
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Type Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Greiner Bio-One
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Type Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Hubrecht Organoid Technology (HUB)
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Type Benchmarking
    • 10.7.4. Recent Development
  • 10.8. InSphero
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Type Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Lonza
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Type Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Merck KGaA
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Type Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Prellis Biologics
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Type Benchmarking
    • 10.11.4. Recent Development
  • 10.12. STEMCELL Technologies Inc.
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Type Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Thermo Fisher Scientific, Inc.
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Type Benchmarking
    • 10.13.4. Recent Development

List of Tables:

  • Table 1 Global Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 2 Global Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 3 Global Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 4 North America: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 5 North America: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 6 North America: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 7 U.S.: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 8 U.S.: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 9 U.S.: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 10 Canada: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 11 Canada: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 12 Canada: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 13 Europe: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 14 Europe: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 15 Europe: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 16 UK: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 17 UK: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 18 UK: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 19 France: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 20 France: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 21 France: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 22 Germany: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 23 Germany: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 24 Germany: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 25 Italy: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 26 Italy: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 27 Italy: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 28 Spain: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 29 Spain: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 30 Spain: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 31 Netherlands: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 32 Netherlands: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 33 Netherlands: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 34 Russia: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 35 Russia: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 36 Russia: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 37 Rest of Europe: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 38 Rest of Europe: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 39 Rest of Europe: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 40 Asia Pacific: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 41 Asia Pacific: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 42 Asia Pacific: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 43 China: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 44 China: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 45 China: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 46 India: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 47 India: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 48 India: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 49 Malaysia: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 50 Malaysia: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 51 Malaysia: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 52 Japan: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 53 Japan: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 54 Japan: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 55 Indonesia: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 56 Indonesia: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 57 Indonesia: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 58 South Korea: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 59 South Korea: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 60 South Korea: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 61 Australia: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 62 Australia: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 63 Australia: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 64 Rest of Asia Pacific: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 65 Rest of Asia Pacific: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 66 Rest of Asia Pacific: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 67 Middle East & Africa: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 68 Middle East & Africa: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 69 Middle East & Africa: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 70 Saudi Arabia: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 71 Saudi Arabia: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 72 Saudi Arabia: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 73 UAE: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 74 UAE: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 75 UAE: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 76 Israel: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 77 Israel: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 78 Israel: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 79 South Africa: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 80 South Africa: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 81 South Africa: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 82 Rest of Middle East & Africa: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 83 Rest of Middle East & Africa: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 84 Rest of Middle East & Africa: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 85 Latin America: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 86 Latin America: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 87 Latin America: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 88 Mexico: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 89 Mexico: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 90 Mexico: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 91 Brazil: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 92 Brazil: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 93 Brazil: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 94 Argentina: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 95 Argentina: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 96 Argentina: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 97 Rest of Latin America: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 98 Rest of Latin America: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 99 Rest of Latin America: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • List of Figures:
  • Figure 1. Global Organoids and Spheroids Market, 2019-2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Type
  • Figure 7. Global Organoids and Spheroids Market, by Type, 2023 & 2032 (USD Million)
  • Figure 8. Market by Application
  • Figure 9. Global Organoids and Spheroids Market, by Application, 2023 & 2032 (USD Million)
  • Figure 10. Market by End Use
  • Figure 11. Global Organoids and Spheroids Market, by End Use, 2023 & 2032 (USD Million)